Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19

• প্রধান লেখক: V. A. Otdelenov (লেখক), K. B. Mirzaev (লেখক), D. A. Sychev (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Izdatelstvo OKI, 2020-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interactions.